Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹815 Cr
Revenue (TTM)
₹658 Cr
Net Profit (TTM)
₹65 Cr
ROE
84.2 %
ROCE
36 %
P/E Ratio
12.6
P/B Ratio
6.6
Industry P/E
44.74
EV/EBITDA
9.2
Div. Yield
0 %
Debt to Equity
3.4
Book Value
₹35.2
EPS
₹19.2
Face value
10
Shares outstanding
34,939,398
CFO
₹300.59 Cr
EBITDA
₹184.98 Cr
Net Profit
₹207.43 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Wanbury
| 1.1 | -8.4 | 1.1 | -7.2 | 79.7 | 21.9 | 17.4 |
|
BSE Healthcare
| -4.7 | -5.3 | -6.0 | 2.1 | 23.3 | 13.9 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Wanbury
| -23.5 | 127.0 | 157.2 | -41.5 | 71.1 | 150.1 | -9.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Wanbury
|
229.1 | 815.0 | 657.7 | 64.7 | 14.0 | 77.7 | 12.6 | 6.6 |
| 2,203.0 | 17,522.9 | 1,215.1 | 284.8 | 28.7 | 21.1 | 61.1 | 11.5 | |
| 651.2 | 12,800.2 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.4 | 2.3 | |
| 627.4 | 15,409.3 | 5,092.5 | 545.5 | 15.9 | 14.1 | 28.2 | 3.7 | |
| 850.8 | 13,261.8 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.6 | 2.0 | |
| 1,028.0 | 18,428.6 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,402.8 | 16,161.6 | 1,419.3 | 20.1 | 8.4 | 0.5 | 804 | 2.8 | |
| 139.9 | 18,509.8 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.3 | |
| 393.0 | 15,642.1 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.4 | 3.3 | |
| 1,272.9 | 20,730.8 | 3,151.0 | -10.0 | 8.4 | 2.5 | 942.3 | 4.5 |
2 min read•By Research Desk
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology,... rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India. Read more
Incorporated
1988
Chairman
--
Managing Director
--
Headquarters
Navi Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Wanbury Ltd is ₹229.05 (NSE) and ₹229.05 (BSE) as of 06-Apr-2026 13:19 IST. Wanbury Ltd has given a return of 79.66% in the last 3 years.
The P/E ratio of Wanbury Ltd is 12.60 times as on 06-Apr-2026, a 72 discount to its peers’ median range of 44.74 times.
The P/B ratio of Wanbury Ltd is 6.62 times as on 06-Apr-2026, a 114 premium to its peers’ median range of 3.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.19
|
14.96
|
|
2024
|
8.54
|
22.63
|
|
2023
|
0.00
|
-3.53
|
|
2022
|
3.41
|
-11.25
|
|
2021
|
0.00
|
-1.33
|
The 52-week high and low of Wanbury Ltd are Rs 329.70 and Rs 161.50 as of 06-Apr-2026.
Wanbury Ltd has a market capitalisation of ₹ 815 Cr as on 06-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Wanbury Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-1.34
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.